Type
common
- Bentzen S, Gupta T, Jacinto A, Rosenblatt E, Bhasker S, Napoles M, Binia S, Chansilpa Y, Aguiar S, Nagarajan M, Ghosh Laskar S, Marchi P, Goloubeva O, Hopkins K, Zubizarreta E, Agarwal J, Abdel-Wahab M (2026). Hypofractionated versus normofractionated accelerated radiation therapy with or without cisplatin for locally advanced head and neck squamous cell carcinoma (HYPNO): A randomized, open-label, Phase 3, noninferiority trial. International Journal of Radiation Oncology,Biology,Physic
- Bancroft E, Page E, McHugh J.......Greenhalgh L, Murthy V...etal. (on behalf of the IMPACT Study Collaborators ) , Brook M, Kate-Zarai Z, Eles R (2026). Targeted prostate cancer screening in carriers of BRCA1 or BRCA2 pathogenic germline variants detects clinically relevant disease: 5-year results from the IMPACT study. European Urology.
- Bhandare MS, Nandy K, Parray AM, Pawar A, Padhy A, Menon V, Chopde A, Chaudhari V, Shrikhande SV (2026). Interplay of Post-Pancreatectomy Acute Pancreatitis, Postoperative Pancreatic Fistula, and Mortality after Pancreatoduodenectomy: Insights from a Comprehensive Cohort Study of 1594 Patients and Development of Predictive Nomograms. Journal of the American College of Surgeons.
- Chilukuri S, Sundar SC, Subramani V, Arjunan M, Raveendran V, Kamath R, Meena L, Guruvaiah A, Phurailatpam R, Selvaraj R, Chaudhari L, Kumaar V, Jain N, Tiwari M, Halsana P, Sharma D, Maitre P, Murthy V (2026). Pre-PROTO-PRIME study: Stereotactic body proton therapy to the prostate and pelvic nodes for high-risk and node-positive prostate cancer — feasibility, acute toxicity and dosimetric insights. Clinical and Translational Radiation Oncology.56:101084.
- Dhar A, Siva S, Tan VS, Mahadevan A, Bruynzeel A, Tang C, Cury F, Corkum M, Ali M, Zaorsky NG, Cheung P, Hannan R, Hudes R, Morgan S, Lo S, Murthy V, Correa RJM, Swaminath A (2026). International Radiosurgery Oncology Consortium of the Kidney (IROCK) contouring guidelines for renal cell carcinoma treated with stereotactic ablative radiotherapy. International Journal of Radiation Oncology, Biology, Physics.
- Gohil D, Gandhi KA, Gupta SK, Gera P, Yadav S, Patwardhan R, Checker R, Sharma D, Khattry N, Sandur S, Gota V( 2026). Immunomodulation by juglone alleviates acute graft-versus-host disease without compromising the graft-versus-leukaemia activity in mice. British Journal of Pharmacology. 183(1):131-152.PMID: 38584000
- Gupta R, Fielder T, Bal M..........Chernock R...Kamboj M...Patil A...Rane S...etal. on the behalf of the HN-CLEAR steering committee and clinical advisory group (2026). International consensus recommendations and alignment of terminology for the histopathological diagnosis of extranodal extension in head and neck squamous cell carcinoma: an HN-CLEAR initiative. Lancet Oncology. 27(1):e33-e44.
- Guha A, Gawde J, Mahajan K, Bagal B, Parab A, Rajeshwari A, Shetty N, Kulkarni S (2026). Is looking at the tip of the iceberg sinking our ship? A longitudinal cohort study on the patterns of evolution on treatment of non-enhancing FLAIR lesions in primary CNS lymphoma. Journal of Neurooncology. 177(1):7
- Gupta S, Nair N, Hawaldar RW, Joshi S, Gulia S, Shet T, Sarin R, Parmar V, Desai S, Ghosh J, Wadasadawala T, Vanmali V, Panhale T, Parab P, Patil A, Chitkara G, Rath S, Bajpai J, Pathak R, Popat P, Thakur M, Badwe RA (2026). Addition of Carboplatin to Sequential Taxane-Anthracycline Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Phase III Randomized Controlled Trial. Journal of Clinical Oncology. 44(1):9-19. PMID: 41115255
- Kumar A, Gurav M, Sarkar J, Bapat P, Madhu K, Shetty O, Chatterjee A, Sahay A, Dasgupta A, Moiyadi A, Shetty P, Gupta T, Goda JS, Epari S (2026). Impact of IDH mutation and MGMT methylation as Independent prognostic markers in uniformly treated high grade glioma Patients: A Real-World evidence in the Indian Population. Brain Research. 1877-1878:150205.
- Krishnamurthy Manjunath N, Patil V, Shirsat A, Wairagade S, Pradosh A, Kumar S, Jadhav S, Chavan A, Patil A, Joshi A, Prabhash K, Gota V, Noronha V (2026). A prospective, open-label, randomized, crossover study to compare the pharmacokinetics of crushed methotrexate with that of the tablet formulation in patients with head-and-neck cancer. Cancer Research, Statistics and Treatment 9(1):1-7.
- Kumari A, Mal A, Thorat R, Saha P, Patel P, Valvi S, CM Krishna, De A, Bandyopadhyaya R (2026). Sustained and localized delivery of gemcitabine using chitosan-PVA-TPP polymeric implant enhances antitumor efficacy and delays surgical relapse in pancreatic cancer. Biomaterials Advances. 179: 214489. PMID: 40976113
- Kizhakethil RV, Varma AK, Bhogale OV, Joshi MA, Barage SH, Kumar AWS, Kamble SS (2026). Conformational dynamics and energetic perturbations in human β-spectrin-II mediated by calpain cleavage-related mutations: Insights from enhanced sampling simulations. Computational Biology and Chemistry.120(Pt 2):108759.PMID: 41192394.
- Karale B, Tambe M, Rajak J, D'Silva SZ (2026). Identification of the Novel HLA-B Allele, HLA-B*57:198, in an Individual From North India. HLA. 107(1):e70538
- Iengar P, Venkatraman P (2026). Using the reactome graph database to generate pathway fingerprints for cancer-related genes, and using the fingerprints to gain insights into cancer, comorbidity, and cancer gene networks. Computational Biology and Chemistry. 120 Part 1: 108686.PMID: 41252800
- Malhotra R, Moitra P, Chatterjee A, Kota PK, Dasgupta A, Epari S, Menon N, Kowtal P, Sarin R, Gupta T (2026). Clinical and genetic predictors of temozolomide-induced severe myelotoxicity in adult diffuse glioma: a case-control study. Journal of Neurooncology. 177(1):9.
- Meher R, Maharana J, Kavvuri J, K Nirmal Kumar, Pradhan T, Kailaje V, Ingle A, Sen S, Barkume M, Patkar M, Vaibhaw A, Mir SA, Ghosh A, Kamte S, Kamal A, Kode J (2026). A Phenstatin-based indole-chalcone hybrid as novel anti-inflammatory agent targeting the NLRP3 Inflammasome: Leads from computational and preclinical studies. Bioorganic Chemistry.170:109429.
- Patwardhan R, Rizvi Z, Gota V, Checker R, Singh B, Maurya D, Pal D, Ramani N, Kumar BK, Purohit V, Mathapati BS, Mullick J, Ghanty T, Gupta S, Joshi M, Madki S, Awasthi A, Sandur S, Sharma D (2026). First-in-human clinical trial of high-dose sodium copper chlorophyllin: Pharmacology and efficacy as a dual immunomodulatory/antiviral agent. Phytomedicine. 150: 157689. PMID: 41453293
- Pradhan P, Chaudhary T, Mishra S, Konik P, Durinova E, Tuma R, De A, Sinha D (2026). MCJ modulates mitochondrial ETC flux to promote lipid metabolism-driven enhancement of cell proliferation and migration. Cell Death and Disease.
- Siddiqui A, Dhandapani H, Rather A, Ingle A, Sharma D, Tayalia P (2026). In situ programming of CAR-macrophages via a polyplex nanomaterial and STING activation for triple-negative breast cancer immunotherapy. Nanoscale.
- Sandbhor P, Goda J, Banerjee R, Dyawanapelly S (2026).Targeted dual-drug delivery for minimal residual glioblastoma using multifunctional thermosensitive liposomal hydrogels. Journal of Drug Delivery Science and Technology.
- Sinha S, Ghosh Laskar S, Dhingra S, Kumar A, Mohanty S, Budrukkar A, Swain M, Bishnu PN, Joy I, Ali R, Kannan S, Mummudi N (2026). Avoiding adjuvant Prophylactic Neck irradiation in lateralized oral cavity cancer (APRON). Clinical Oncology. 49: 103980
- Subramani V, Chauhan, H, David S, Maitre P, Menon S, Joshi A, Misra A, Arora A, Pal M, Prakash G, Murthy V (2026). Efficacy and safety of adjuvant radiotherapy in primary resected adrenocortical carcinoma – A comparative study. Journal of UroOncology 1(1): 24-30.
- Mirgh S, Sood K, Punatar S, Gokarn A, Chichra A, Nayak L, Bain G, Bagal B, Khattry N (2025). MRD directed consolidation in multiple myeloma – Are we there yet? Clinical Lymphoma Myeloma and Leukemia.
- Shenoy V, Kannan S, Noronha V, Prabhash K, Ostwal V, Bhargava P, Pillai A, Shamseeya K, Shetake A, Dhekale R, Chitre A, Gota V, Mahajan S, Daptardar A, Sonkusare L, Deodhar J, Ansari N, Vagal M, Mahajan P, Nookala M, Banavali SD, Ramaswamy A (2026). Development of a new model for prediction of relevant treatment related adverse events in older individuals with gastrointestinal cancers. Journal of Geriatric Oncology. 17(2):102817.
- Sahu A, Mehta D, Dasgupta A, Dev I, Puranik A, Bhattacharya K, Sahay A, Sridhar E, Shetty P, Moiyadi A, Menon N, Chatterjee A, Gupta T (2026). Patterns of radiation-induced subependymal enhancement in patients with high-grade glioma. Neuroradiology Journal.
- George A, Nair S, Prabhash K, Thakur S, Gera P, Singh A, Chaturvedi P, Rane S, Pradhan T, Sen S, Barkume M, Shetty D, Chaubal K, Ghosh A, Kamte S, Kode J (2026). Generation and characterization of early stage oral cancer cell line of buccal mucosa of Indian origin. Human Cell. 39: 21.
- Vatsa P, Chaudhary B, Kamble A, Waghmare S, Sharma S, Mandoli A (2026).Disrupting microtubule dynamics to rewire apoptosis, differentiation, and EMT programs in oral squamous cell carcinoma through indenamine derivatives. Bioorganic & Medicinal Chemistry.132:118444
Category
Select Year
order
8